A Group of Lawmakers Want to Make It Easier for Psychedelic Research, Compassionate Use

A group of federal lawmakers seeks to remove regulatory barriers that inhibit psychedelics in research and compassionate use cases. Senators Cory Booker (D-N.J.) and Rand Paul (R-KY) introduced an updated version of the Breakthrough Therapies Act to the Senate. If passed, the bill would make it easier to use Schedule 1 drugs with a breakthrough […]

Why 2023 Could Be a Pivotal Year for Psychedelic-Assisted Treatment

After years of regulatory hurdles and societal stigma, psychedelic-assisted treatment for behavioral health conditions is coming into the spotlight. The growing popularity of psychedelics is due, in part, to promising research results and multiple states relaxing regulations. Now, 2023 could be a banner year for the treatment. Psychedelic legalization is going into effect in the […]

Virtual Ketamine Startup Nue Life Launches B2B Offering with New Partnership Program

Ketamine therapy startup Nue Life will offer its services to health systems, medical networks and prescribers in all 50 states through its new partnership program. Dubbed Nue Network, the program allows partners to provide patients with at-home ketamine treatment and integrated therapy programs. In addition to the medication, the program also gives patients access to […]

Psychedelics Company Numinus Acquires Novamind to Fuel US Expansion

Yet another company that uses psychedelics to treat mental illness is moving into the U.S. market. In June, ​Vancouver, Canada-based Numinus Wellness (TSX: NUMI) expanded its geographic footprint into the U.S. with its acquisition of Novamind, a mental health company specializing in psychedelic medicine. Novamind is headquartered in Toronto, but its clinics are located in […]

Therapeutic Ketamine Providers Seeing Growth, But Guardrails Are Needed

Therapeutic ketamine providers are seeing growth and positive patient outcomes, but companies caution that the business requires guardrails as it expands. The drug ketamine was originally invented in the 1960’s as a surgical anesthetic for humans and animals. But ketamine’s dissociative and hallucinogenic properties meant people have also used it recreationally, and more recently, for […]

Osmind Raises $40M to Scale Mental Health Treatment, Research EHR

Public benefit corporation Osmind Inc. announced Tuesday it completed a $40 million Series B funding round. The San Francisco-based startup will use the funding to further develop its electronic health record (EHR) technology for mental health research and treatment, advance research with new partners, and double the size of its workforce, according to a news […]